Redirect Notice
 The previous page is sending you to https://www.researchgate.net/figure/MACE-by-baseline-CV-risk-profile-in-all-patients-receiving-tofacitinib-in-the-PsO-cohort_fig4_368340065.

 If you do not want to visit that page, you can return to the previous page.